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a b s t r a c t
Recent study demonstrated a close relationship between cerebellum atrophy and symptom severity of
pediatric maltreatment-related posttraumatic stress disorder (PTSD). It has also been known that females
are more vulnerable than males in developing anxiety disorders after exposure to traumatic stress. The
mechanisms are unknown. Because cannabinoid receptors (CB1 and CB2 ) are neuroprotective and highly
expressed in the cerebellum, we investigated cerebellar CB expression in stressed rats. Young male and
female Sprague-Dawley rats were given 40 unpredictable electric tail-shocks for 2 h daily on 3 consecutive days. CB1 and CB2 mRNA and protein levels in rat cerebellum and brain stem were determined using
quantitative real-time PCR and Western blot, respectively. Two-way ANOVA revealed signiﬁcant gender and stress effects on cerebellar CB1 mRNA expression, with females and non-stressed rats exhibiting
higher CB1 mRNA levels than the males (3 fold, p < 0.01) and stressed rats (30%, p < 0.01), respectively. CB1
and CB2 mRNA levels in brain stem were also greater in female rats than males (p < 0.01, p < 0.05, respectively). Repeated stress increased the level of phosphorylated CB1 receptors, the inactivated CB1 , in rat
cerebellum (p < 0.01), particularly in female rats as revealed by the signiﬁcant gender × stress interaction.
Thus, repeated severe stress caused greater CB1 mRNA suppression and CB1 receptor phosphorylation in
female cerebellum that could lead to increased susceptibility to stress-related anxiety disorders including
PTSD.
© 2011 Elsevier Ireland Ltd. All rights reserved.

Mounting evidence implicates a critical role of cannabinoid
receptors (CB1 and CB2 ) in stress-related anxiety disorders and
emotional memory. CB1 knockout animals show hypersensitivity
to stressful stimuli, decreased sociability, increased aggressive and
anxiety-like behaviors and disrupted response to anxiolytic drugs
[19,28,46]. CB1 knockout animals and CB1 antagonist-treated animals also show marked inability to extinguish fear memory [27].
These characteristics parallel the core clinical features of individuals with post-traumatic stress disorder (PTSD), i.e. reduced
threshold of fear, impaired extinction of fear memory, vivid recall
or ﬂashbacks of traumatic memories and a high prevalence of
cannabis abuse [23,36,49].
Despite the highest expression of cannabinoid receptors (CB1
and CB2 ) found in the cerebellum [20,25,48], its functional role
remains to be established. To our knowledge, no one has reported
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cerebellar cannabinoid receptor expression under stressed conditions.
It is known that females are more vulnerable to traumatic stress
and show a higher prevalence of stress-related anxiety disorders
than males (2–3 fold) [7,39]. Yet many animal model studies of
stress are based on male animals only; the generalizability of the
male animal-based ﬁndings for females is limited accordingly. In
this study, we examined CB1 and CB2 expression levels in the cerebellum and brain stem of young adult male and female rats, and
the responses to repeated tail-shock stress.
Young juvenile male and female Sprague-Dawley rats (Taconic
Farms, Germantown, NY, USA) weighing 100–150 g (5–6 weeks
old) were unisex and pair-housed, with wood chip bedding, and
maintained at a room temperature of 22 ± 2 ◦ C on a 12-h light-dark
schedule (lights on 1800 h), and left undisturbed for 7 days before
the start of the stress protocol that consisted of one 2-h per day session of restraint immobilization stress plus unpredictable repeated
tail-shocks over 3 consecutive days. The animals were restrained
in a Plexiglas tube and given 40 electric shocks (2 mA, 3 s duration) at varying intervals (140–180 s). Animals in the control group
were handled daily as those in the stress group, but without going
through the stress procedure.
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After the last stress session on day 3, both the control animals
and the stressed animals were decapitated after light anesthesia
with halothane. The brains were rapidly removed, dissected and
kept at −70 ◦ C for real-time PCR and western blotting (Appendix
1). Half of the dissected cerebellum and brain stem of each animal
were homogenized for total RNA extraction with RNeasy kit (Qiagen) and reverse transcription into ﬁrst-strand cDNA with a reverse
transcriptase kit (Sigma, St. Louis).
The qPCR and western blot data were represented as mean ± s.d.
The effects of gender and repeated stress on CB1 and CB2 receptor
expression and phosphorylation in cerebellum and brain stem were
analyzed using two-way ANOVA. As signiﬁcant gender × stress
interactions were found in CB1 mRNA expression and receptor
phosphorylation, one-way ANOVA was conducted to evaluate the
effect of stress within each sex. p < 0.05 was considered statistically
signiﬁcant.
The qPCR data showed that CB1 mRNA levels were much higher
than CB2 mRNA in the cerebellum and brain stem of both male and
female control rats as shown by the CB1 :CB2 mRNA ratio (>30 fold)
based on the Ct values of each receptor (Appendix 2). This is consistent with previous ﬁndings of high CB1 expression in cerebellum
[20].
Two-way ANOVA revealed signiﬁcant main effects of gender
(p < 0.01) and repeated stress (p < 0.01), as well as signiﬁcant gender × stress interaction (p < 0.01) on CB1 mRNA expression in rat
cerebellum, with females and non-stressed rats exhibited higher
CB1 mRNA levels than the males (3 fold) and stressed rats (30%),
respectively (Fig. 1A). The signiﬁcant gender × stress interaction
suggests a greater stress-induced reduction of CB1 mRNA in the
female cerebellum (p < 0.01) than in males (p < 0.05) as revealed by
the within-sex 1-way ANOVA (Fig. 1A). Two-way ANOVA showed
signiﬁcant gender, but no stress effect on CB1 mRNA expression
level in the brain stem, with female rats showing higher level than
male rats (p < 0.01) (Fig. 1B). CB2 mRNA expression level tended
to be greater in the cerebellum and signiﬁcantly greater in the
brain stem (p < 0.05) of female rats than males (Fig. 1C and D). No
signiﬁcant stress effect was found in brain stem CB2 mRNA.
No signiﬁcant gender and stress effects were found on total
CB1 and CB2 proteins expressed in rat cerebellum and brain stem
(Figs. 2 and 3). However, phosphorylated CB1 receptor (p-CB1 ),
the inactivate form of CB1 receptors, was signiﬁcantly increased
in the cerebellum of the stressed rats (2-way ANOVA, p < 0.01),
especially in the stressed females (Fig. 2A). Further, a signiﬁcant
stress × gender interaction existed in cerebellar p-CB1 protein level
suggesting a greater p-CB1 level in the female cerebellum as supported by the within-sex 1-way ANOVA (p < 0.01) (Fig. 2A). Because
CB1 receptor phosphorylation has been shown to be associated with
increased internalization and desensitization of CB1 receptors [18],
the increased p-CB1 receptors suggest increased inhibition of CB1
receptor activity in the cerebellum of stressed animals.
The gender difference in cerebellar CB1 and CB2 mRNA expression is consistent with the reports of greater endocannabinoid
content in the brains of female rats [5] and a greater CB1 mRNA
expression in the blood cells of female human subjects [34].
Gender differences have also been reported in the amount of
self-administered CB1 agonists, in brain metabolism and behavioral effects of ␦9 -tetrahydrocannabinol (␦9 -THC, the main active
component of marijuana and potent CB1 agonist) in rodents,
with females self-administering more CB1 agonists, producing signiﬁcantly more of the active metabolite of THC and enhanced
THC-induced behavioral effects including antinociception, motoric
effects, catalepsy and hypothermia [10,16,33,44,45]. Although the
mechanism is unknown, sex hormones and the estrous cycle may
be involved in the gender difference in CB1 and CB2 receptor
expression. There are reports that ovariectomy (OVX) decreased,
whereas acute and chronic estradiol or progesterone administra-

tion increased the density of cannabinoid receptors in the limbic
forebrain and in the hypothalamic nucleus of intact and OVX female
rats [40]. As the present female rats were in the pubertal stage and
their estrous cycles were not controlled, this could have potentially contributed to the higher variability in CB1 and CB2 receptor
expression in the female brain.
The higher CB1 mRNA expression levels but lower CB1 protein
expression levels in the brain stem of females than males suggest a differential regulation of CB1 mRNA and protein expression
between the sexes. While the mechanism is unknown, a potentially greater turnover/degradation rate of CB1 receptor protein in
the females could have triggered a need for greater CB1 mRNA
expression. Differential modiﬁcation of the CB receptor (phosphorylation, glycosylation) induced by sex hormones could cause
sex-dependent changes in the afﬁnity and immunogenic activity
of CB receptors as detected by the antibodies in this study and
others [14]. Furthermore, the greater metabolic rate of cannabinoids reported in the females could cause a parallel increase in CB1
protein turnover and CB1 mRNA expression.
A difference in circulating corticosterone level could also be
responsible for the observed sex-dimorphism in CB1 mRNA expression. It is known that females have higher basal corticosteroid levels
and greater stress-induced corticosteroid secretion but slower corticosteroid clearance from circulation [8,9]. Chronic exposure to
corticosterone, CB1 agonists and cannabinoids has been shown to
downregulate CB1 receptor density, CB1 receptor binding and CB1
mRNA expression in brain regions such as cerebellum and hippocampus [15,22,26,37,41].
Although no signiﬁcant stress effect was found in CB expression in brain stem, this may reﬂect the technical limitations of
present study. Because brain stem tissue homogenates were used
in this study, the results are not conclusive regarding changes in
CB receptor expression in speciﬁc nuclei of the brain stem. Further
immunohistochemistry/in situ hybridization studies are required
to determine speciﬁc changes in cannabinoid receptor expression
in these nuclei after stress and their correlations with behavioral
changes in PTSD models. Cannabinoid receptors expressed in the
periaqueductal gray, locus coeruleus, raphe nuclei, reticular activating system, solitary tract, vestibular and cochlear nuclei of brain
stem are thought to play important roles in the regulation of pain
sensation, sleep-awake cycle, acoustic startle response, cardiovascular reactivity that are frequently altered in subjects with PTSD
[1,2,12,30–32,38,48].
Since stress enhances norepinephrine (NE) synthesis/turnover
in the LC and its subsequent release in the basolateral amygdala via
alpha1A adrenergic receptor located in the presynaptic terminals,
intense sympathetic activation and local NE release could regulate CB expression/activity via the release of eCBs. Alternatively,
CB1 receptors in the brain stem could potentially interacts with
the alpha2-adrenergic autoreceptors to inhibit norepinephrine
release from the adrenergic neurons of the locus coeruleus under
physiological conditions [42]. Our studies show that the stress differentially suppressed brain adrenergic receptor mRNA expression
between male and female rats, with a sex-dimorphism opposing
that of brain CB mRNA expression (manuscript in preparation).
Thus, brain CB and adrenergic systems could interact in central
regulation of cardiovascular response in stress-induced anxiety disorders [6].
A recent study showed that acute maternal deprivation significantly increased neuronal apoptosis in the cerebellum of male
rat pups and that induction was attenuated by inhibiting endogenous cannabinoid (eCBs) degradation [24]. As brain eCBs activity
is mainly mediated by CB1 receptors, that study implicates an
important anti-apoptosis role of CB1 receptor in stressed cerebellum. Another brain imaging study showed signiﬁcant correlations
between structural volumes of the cerebellar hemispheres and clin-

G. Xing et al. / Neuroscience Letters 502 (2011) 5–9

A. Cerebellum

B. Brain stem

8
6
a

4

**

2
0

*
Male

C. Cerebellum

6
a

4
2

Male

Female

D. Brain stem
Brain stem CB2 mRNA

8

6

4

2

0

Control
3d stress

8

0

Female

8

Cerebellar CB2 mRNA

* : P<0.05, stress vs control, within sex
**: P<0.01, stress vs control, within sex
a: P<0.01, female control vs male control
b: P<0.05, female control vs male control

10

Brain stem CB1 mRNA

Cerebellar CB1 mRNA

10

7

Male

Female

6
b

4

2

0

Male

Female

Fig. 1. Effects of gender and stress on CB1 and CB2 mRNA. (A), Cerebellar CB1 mRNA level was signiﬁcantly higher in the female rats (n = 16) than in the males (n = 16, p < 0.01)
and in the non-stressed animals (n = 16) than in the stressed animals (n = 16, p < 0.01), respectively. Three days repeated stress down-regulated CB1 mRNA level in male
(p < 0.05) and female rats (p < 0.01) when compared with same sex controls; (B), Brain stem CB1 mRNA was signiﬁcantly greater in female rats than in male rats (p < 0.01) but
no stress effect was found; (C), Cerebellar CB2 mRNA was not affected by sex or stress; (D), Brain stem CB2 mRNA level was signiﬁcantly higher in female rats than in the
males (p < 0.05). The mean value of the male control group (mean ± s.d.) was used as the arbitrary reference (=1). Black column: control rats; gray column, stressed rats, a,
p < 0.01, male control vs. female control; b, p < 0.05, male control vs. female control; *p < 0.05; **p < 0.01, within-sex 1-way ANOVA.

Fig. 2. Western blotting of CB proteins in rat cerebellum. Top panel, representatives of cerebellum western blotting: twenty micrograms (g) of rat cerebellum tissue
homogenates were resolved on SDS-PAGE gel and incubated with the speciﬁc CB antibodies and detected using an ECL western blot detecting system. Bottom pane, (A),
phosphorylated CB1 proteins (p-CB1 ); (B), semi-quantitative western blotting of total CB1 proteins; (C), CB2 proteins and; (C) in rat cerebellar tissue homogenates with or
without 3 days repeated tail-shock stress. The mean value (mean ± s.d.) of the male control group (n = 8) was used as the arbitrary reference (=1) for other groups (n = 8).
Two-way ANOVA revealed signiﬁcantly elevated p-CB1 protein in the stressed animals, primarily in the females, *p < 0.05; Black column, control group; gray column, stress
group (n = 8 each group).
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Fig. 3. Western blotting of CB proteins in rat brain stem. Top panel, representatives of cerebellum western blotting: twenty micrograms (g) of rat brain stem tissue
homogenates were resolved on SDS-PAGE gel and incubated with the speciﬁc CB primary antibodies and detected using an ECL western blot detecting system. Bottom panel,
semi-quantitative western blotting of: (A) phosphorylated CB1 proteins (p-CB1 ); (B) total CB1 proteins and; (C) CB2 proteins in rat brain stem tissue homogenates with or
without 3 days repeated tail-shock stress. The mean value (mean ± s.d.) of the male control group (n = 8) was used as the arbitrary reference (=1) for other groups (n = 8).
Black column: control group; gray column, stressed group.

ical symptoms in pediatric maltreatment-related PTSD. The PTSD
subjects had signiﬁcantly reduced volume in both the left and
the right hemispheres and in total cerebellum volume [11]. These
studies implicate a link between stress-induced apoptosis and cerebellum atrophy in PTSD although the exact causative factors and
the time course of the atrophy remain to be established. Our study
suggests that chronic stress-induced CB1 receptor suppression in
early development could be involved in the cerebellar neuronal
apoptosis or structural atrophy in PTSD.
It is known that females are more vulnerable than males after
exposure to trauma [4,28]. The molecular mechanism is unknown.
In this study, the stressed female rats showed a greater reduction
in CB1 mRNA expression but a greater increase in cerebellum CB1
receptor phosphorylation (at serine 316) than the stressed males.
Because phosphorylation at serine 316 of CB1 receptor by protein
kinase C is a key post-translational regulatory mechanism underlying rapid CB1 receptor internalization and desensitization by
disrupting cannabinoids-mediated activation of inwardly rectifying potassium current and depression of P/Q-type calcium channels
x [18], this phosphorylation of CB1 receptors would represent
another novel mechanism of rapid CB1 inhibition in the cerebellum of stressed female rats. Other studies suggest that it is the rate
of change rather than absolute level that can bring about swings in
mood and anxiety.
It is tempting to speculate that chronic stress-induced CB1
receptor downregulation and inhibition could also be involved
in increased marijuana use and cerebellum dysfunction such as
altered time sense in PTSD [47]. While further studies are needed
to evaluate this notion, impaired time sense has been reported in
marijuana users who exhibited cerebellar hypoactivity in response
to delta-9-tetrahydrocannabinol [29]. Because marijuana use is
common among PTSD subjects and is correlated with the severity
of PTSD symptoms [3], the greatly altered CB1 mRNA expression
and receptor phosphorylation/desensitization in stressed female
cerebellum is consistent with the literature that women are more
vulnerable to traumatic stress, become drug dependent more

quickly and are more likely to experience craving than men
[4,7,13,17,21,35,43].
In summary, we observed signiﬁcant gender and repeated stress
effects and their interaction on CB1 mRNA expression and CB1
receptor phosphorylation in rat cerebellum. The greater CB1 mRNA
expression level in female cerebellum is more vulnerable than
that of males after exposure to repeated stress. The rapid CB1
receptor phosphorylation in cerebellum after stress could also be
a biomarker for increased anxiety in females after exposure to
repeated traumatic stress. If replicated, these ﬁndings could help
to design gender-speciﬁc pharmacological interventions for stressinduced anxiety disorders.
Conﬂict of interest
All authors declare no conﬂict of interest.
Acknowledgments
This work was supported by the Center for the Study of Traumatic Stress, Uniformed Services University of the Health Sciences.
We would like to thank Drs. Kwang H. Choi and Frances H. Gabbay
for comments on the manuscript.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.neulet.2011.05.013.
References
[1] G.J. Asmundson, M.J. Coons, S. Taylor, J. Katz, PTSD and the experience of pain:
research and clinical implications of shared vulnerability and mutual maintenance models, Can. J. Psychiatry 47 (2002) 930–937.
[2] G.J. Asmundson, J. Katz, Understanding pain and posttraumatic stress disorder
comorbidity: do pathological responses to trauma alter the perception of pain?
Pain 138 (2008) 247–249.

G. Xing et al. / Neuroscience Letters 502 (2011) 5–9
[3] M.O. Bonn-Miller, A.A. Vujanovic, M.T. Feldner, A. Bernstein, M.J. Zvolensky,
Posttraumatic stress symptom severity predicts marijuana use coping motives
among traumatic event-exposed marijuana users, J. Trauma. Stress 20 (2007)
577–586.
[4] M.A. Bornovalova, P. Ouimette, A.V. Crawford, R. Levy, Testing gender effects
on the mechanisms explaining the association between post-traumatic stress
symptoms and substance use frequency, Addict. Behav. 34 (2009) 685–
692.
[5] H.B. Bradshaw, N. Rimmerman, J.F. Krey, J.M. Walker, Sex and hormonal cycle
differences in rat brain levels of pain-related cannabimimetic lipid mediators,
Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 (2006) R349–R358.
[6] M.F. Braga, V. Aroniadou-Anderjaska, S.T. Manion, C.J. Hough, H. Li,
Stress impairs alpha(1A) adrenoceptor-mediated noradrenergic facilitation of
GABAergic transmission in the basolateral amygdala, Neuropsychopharmacology 29 (2004) 45–58.
[7] N. Breslau, H.D. Chilcoat, R.C. Kessler, E.L. Peterson, V.C. Lucia, Vulnerability to
assaultive violence: further speciﬁcation of the sex difference in post-traumatic
stress disorder, Psychol. Med. 29 (1999) 813–821.
[8] I. Butkevich, V. Mikhailenko, P. Semionov, T. Bagaeva, V. Otellin, A.M. Aloisi,
Effects of maternal corticosterone and stress on behavioral and hormonal
indices of formalin pain in male and female offspring of different ages, Horm.
Behav. 55 (2009) 149–157.
[9] K.A. Caudell, B.B. Gallucci, Neuroendocrine and immunological responses of
women to stress, West. J. Nurs. Res. 17 (1995) 672–692.
[10] R.M. Craft, Sex differences in behavioral effects of cannabinoids, Life Sci. 77
(2005) 2471–2478.
[11] M.D. De Bellis, M. Kuchibhatla, Cerebellar volumes in pediatric maltreatmentrelated posttraumatic stress disorder, Biol. Psychiatry 60 (2006) 697–703.
[12] A. Dogrul, L.R. Gardell, S. Ma, M.H. Ossipov, F. Porreca, J. Lai, ‘Knock-down’ of
spinal CB1 receptors produces abnormal pain and elevates spinal dynorphin
content in mice, Pain 100 (2002) 203–209.
[13] M. Driessen, S. Schulte, C. Luedecke, I. Schaefer, F. Sutmann, M. Ohlmeier,
U. Kemper, G. Koesters, C. Chodzinski, U. Schneider, T. Broese, C. Dette, U.
Havemann-Reinicke, Trauma and PTSD in patients with alcohol, drug, or dual
dependence: a multi-center study, Alcohol. Clin. Exp. Res. 32 (2008) 481–488.
[14] M. Egertova, M.R. Elphick, Localisation of cannabinoid receptors in the rat brain
using antibodies to the intracellular C-terminal tail of CB, J. Comp. Neurol. 422
(2000) 159–171.
[15] F. Fan, Q. Tao, M. Abood, B.R. Martin, Cannabinoid receptor down-regulation
without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in
the cerebellum of CP 55,940-tolerant mice, Brain Res. 706 (1996) 13–20.
[16] L. Fattore, M.S. Spano, S. Altea, F. Angius, P. Fadda, W. Fratta, Cannabinoid selfadministration in rats: sex differences and the inﬂuence of ovarian function,
Br. J. Pharmacol. 152 (2007) 795–804.
[17] L. Fattore, M.S. Spano, S. Deiana, V. Melis, G. Cossu, P. Fadda, W. Fratta, An
endocannabinoid mechanism in relapse to drug seeking: a review of animal
studies and clinical perspectives, Brain Res. Rev. 53 (2007) 1–16.
[18] D.E. Garcia, S. Brown, B. Hille, K. Mackie, Protein kinase C disrupts cannabinoid
actions by phosphorylation of the CB1 cannabinoid receptor, J. Neurosci. 18
(1998) 2834–2841.
[19] J. Haller, N. Bakos, M. Szirmay, C. Ledent, T.F. Freund, The effects of genetic and
pharmacological blockade of the CB1 cannabinoid receptor on anxiety, Eur. J.
Neurosci. 16 (2002) 1395–1398.
[20] M. Herkenham, A.B. Lynn, M.D. Little, M.R. Johnson, L.S. Melvin, B.R. de Costa,
K.C. Rice, Cannabinoid receptor localization in brain, Proc. Natl. Acad. Sci. U. S.
A. 87 (1990) 1932–1936.
[21] C.A. Hernandez-Avila, B.J. Rounsaville, H.R. Kranzler, Opioid-, cannabis- and
alcohol-dependent women show more rapid progression to substance abuse
treatment, Drug Alcohol Depend. 74 (2004) 265–272.
[22] M.N. Hill, E.J. Carrier, W.S. Ho, L. Shi, S. Patel, B.B. Gorzalka, C.J. Hillard, Prolonged
glucocorticoid treatment decreases cannabinoid CB1 receptor density in the
hippocampus, Hippocampus 18 (2008) 221–226.
[23] K.C. Koenen, M.J. Lyons, J. Goldberg, J. Simpson, W.M. Williams, R. Toomey,
S.A. Eisen, W. True, M.T. Tsuang, Co-twin control study of relationships among
combat exposure, combat-related PTSD, and other mental disorders, J. Trauma.
Stress 16 (2003) 433–438.
[24] M. Lopez-Gallardo, R. Llorente, A. Llorente-Berzal, E.M. Marco, C. Prada, V.
Di Marzo, M.P. Viveros, Neuronal and glial alterations in the cerebellar cortex of maternally deprived rats: gender differences and modulatory effects
of two inhibitors of endocannabinoid inactivation, Dev. Neurobiol. 68 (2008)
1429–1440.
[25] K. Mackie, Distribution of cannabinoid receptors in the central and peripheral
nervous system, Handb. Exp. Pharmacol. (2005) 299–325.

9

[26] R. Malcher-Lopes, A. Franco, J.G. Tasker, Glucocorticoids shift arachidonic
acid metabolism toward endocannabinoid synthesis: a non-genomic antiinﬂammatory switch, Eur. J. Pharmacol. 583 (2008) 322–339.
[27] G. Marsicano, C.T. Wotjak, S.C. Azad, T. Bisogno, G. Rammes, M.G. Cascio, H.
Hermann, J. Tang, C. Hofmann, W. Zieglgansberger, V. Di Marzo, B. Lutz, The
endogenous cannabinoid system controls extinction of aversive memories,
Nature 418 (2002) 530–534.
[28] M. Martin, C. Ledent, M. Parmentier, R. Maldonado, O. Valverde, Involvement of
CB1 cannabinoid receptors in emotional behaviour, Psychopharmacology (Berl)
159 (2002) 379–387.
[29] R.J. Mathew, W.H. Wilson, T.G. Turkington, R.E. Coleman, Cerebellar activity
and disturbed time sense after THC, Brain Res. 797 (1998) 183–189.
[30] T.A. Mellman, A. Kumar, R. Kulick-Bell, M. Kumar, B. Nolan, Nocturnal/daytime
urine noradrenergic measures and sleep in combat-related PTSD, Biol. Psychiatry 38 (1995) 174–179.
[31] C.A. Morgan 3rd, C. Grillon, H. Lubin, S.M. Southwick, Startle reﬂex abnormalities in women with sexual assault-related posttraumatic stress disorder, Am.
J. Psychiatry 154 (1997) 1076–1080.
[32] C.A. Morgan 3rd, C. Grillon, S.M. Southwick, M. Davis, D.S. Charney, Exaggerated
acoustic startle reﬂex in Gulf War veterans with posttraumatic stress disorder,
Am. J. Psychiatry 153 (1996) 64–68.
[33] S. Narimatsu, K. Watanabe, I. Yamamoto, H. Yoshimura, Sex difference in the
oxidative metabolism of delta 9-tetrahydrocannabinol in the rat, Biochem.
Pharmacol. 41 (1991) 1187–1194.
[34] L. Nong, C. Newton, Q. Cheng, H. Friedman, M.D. Roth, T.W. Klein, Altered
cannabinoid receptor mRNA expression in peripheral blood mononuclear cells
from marijuana smokers, J. Neuroimmunol. 127 (2002) 169–176.
[35] S.E. Nunnink, G. Goldwaser, P.S. Heppner, J.O. Pittman, C.M. Nievergelt, D.G.
Baker, Female veterans of the OEF/OIF conﬂict: concordance of PTSD symptoms
and substance misuse, Addict. Behav. 35 (2010) 655–659.
[36] G.T. Okulate, O.B. Jones, Post-traumatic stress disorder, survivor guilt and substance use–a study of hospitalised Nigerian army veterans, S. Afr. Med. J. 96
(2006) 144–146.
[37] A. Oviedo, J. Glowa, M. Herkenham, Chronic cannabinoid administration alters
cannabinoid receptor binding in rat brain: a quantitative autoradiographic
study, Brain Res. 616 (1993) 293–302.
[38] N. Pole, T.C. Neylan, C. Otte, C. Henn-Hasse, T.J. Metzler, C.R. Marmar,
Prospective prediction of posttraumatic stress disorder symptoms using fear
potentiated auditory startle responses, Biol. Psychiatry 65 (2009) 235–240.
[39] L.C. Pratchett, M.R. Pelcovitz, R. Yehuda, Trauma and violence: are women the
weaker sex? Psychiatr. Clin. N. Am. 33 (2010) 465–474.
[40] F. Rodriguez de Fonseca, M. Cebeira, J.A. Ramos, M. Martin, J.J. Fernandez-Ruiz,
Cannabinoid receptors in rat brain areas: sexual differences, ﬂuctuations during
estrous cycle and changes after gonadectomy and sex steroid replacement, Life
Sci. 54 (1994) 159–170.
[41] J. Romero, E. Garcia-Palomero, J.G. Castro, L. Garcia-Gil, J.A. Ramos, J.J.
Fernandez-Ruiz, Effects of chronic exposure to delta9-tetrahydrocannabinol
on cannabinoid receptor binding and mRNA levels in several rat brain regions,
Brain Res. Mol. Brain Res. 46 (1997) 100–108.
[42] E. Schlicker, M. Gothert, Interactions between the presynaptic alpha2autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic
neurones, Brain Res. Bull. 47 (1998) 129–132.
[43] T.P. Sullivan, L.J. Holt, PTSD symptom clusters are differentially related to substance use among community women exposed to intimate partner violence, J.
Trauma. Stress 21 (2008) 173–180.
[44] A.H. Tseng, R.M. Craft, CB(1) receptor mediation of cannabinoid behavioral
effects in male and female rats, Psychopharmacology (Berl) 172 (2004) 25–30.
[45] A.H. Tseng, R.M. Craft, Sex differences in antinociceptive and motoric effects of
cannabinoids, Eur. J. Pharmacol. 430 (2001) 41–47.
[46] L. Uriguen, S. Perez-Rial, C. Ledent, T. Palomo, J. Manzanares, Impaired action
of anxiolytic drugs in mice deﬁcient in cannabinoid CB1 receptors, Neuropharmacology 46 (2004) 966–973.
[47] R.J. Ursano, C.S. Fullerton, Posttraumatic stress disorder: cerebellar regulation
of psychological, interpersonal, and biological responses to trauma? Psychiatry
62 (1999) 325–328.
[48] M.D. Van Sickle, M. Duncan, P.J. Kingsley, A. Mouihate, P. Urbani, K. Mackie, N.
Stella, A. Makriyannis, D. Piomelli, J.S. Davison, L.J. Marnett, V. Di Marzo, Q.J.
Pittman, K.D. Patel, K.A. Sharkey, Identiﬁcation and functional characterization
of brain stem cannabinoid CB2 receptors, Science 310 (2005) 329–332.
[49] S. Vetter, A. Rossegger, W. Rossler, J.I. Bisson, J. Endrass, Exposure to the tsunami
disaster, PTSD symptoms and increased substance use - an Internet based survey of male and female residents of Switzerland, BMC Public Health 8 (2008)
92.

